Rockwell Medical (RMTI) FCF Margin (2010 - 2026)
Rockwell Medical's (RMTI) quarterly FCF Margin came in at 3.61% in Q1 2026, up 1516.0% YoY from 0.22% in Q1 2025, and down 130.56% on a QoQ basis from 11.8% in Q4 2025.
Rockwell Medical (RMTI) FCF Margin (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of FCF Margin data on file, last reported at 3.61% in Q1 2026.
- Quarterly FCF Margin rose 1516.0% year-over-year to 3.61% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.49% (up 28.0% YoY) and the FY2025 annual result came in at 1.79%, down 494.0% from the prior year.
- FCF Margin retreated to 3.61% in Q1 2026, from 11.8% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 14.42% in Q3 2024 to a low of 61.03% in Q1 2022.
- A 5-year average of 8.66% and a median of 5.47% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin jumped 5758 bps — and 2025, when it plunged 2434 bps.
- Tracing RMTI's FCF Margin over 5 years: stood at 2.03% in 2022, then surged by 81 bps to 0.39% in 2023, then jumped by 590 bps to 1.91% in 2024, then surged by 519 bps to 11.8% in 2025, then tumbled by 131 bps to 3.61% in 2026.
- The last three FCF Margin figures came in at 3.61% (Q1 2026), 11.8% (Q4 2025), and 9.91% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.97 Mn | 5.17 Mn | 3.24 Mn | 8.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.41% |
| Mar 31, 2026 | -3.61% |
| Dec 31, 2025 | 11.80% |
| Sep 30, 2025 | -9.91% |
| Jun 30, 2025 | 10.72% |
| Mar 31, 2025 | -18.77% |
| Dec 31, 2024 | 1.91% |
| Sep 30, 2024 | 14.42% |
| Jun 30, 2024 | 4.48% |
| Mar 31, 2024 | -11.11% |
| Dec 31, 2023 | -0.39% |
| Sep 30, 2023 | -15.86% |
| Jun 30, 2023 | -10.07% |
| Mar 31, 2023 | -20.44% |
| Dec 31, 2022 | -2.03% |
| Sep 30, 2022 | -5.47% |
| Jun 30, 2022 | -31.88% |
| Mar 31, 2022 | -61.03% |
| Dec 31, 2021 | -59.61% |
| Sep 30, 2021 | -45.05% |